Taiwan: More flexibility on post-grant amendments

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Taiwan: More flexibility on post-grant amendments

According to Article 67 of the Patent Law, post-grant amendments are permissible only if they are conducted to (1) delete claims; (2) restrict the scope of claims; (3) correct misstatements and mistranslations; or (4) clarify uncertainties. In general, such post-grant amendments shall not go beyond the disclosure of the specification, claims and drawings as originally filed. Nor shall they substantially broaden or alter the scope of the claims.

Recently, Taiwan's IP Office has relaxed the guideline on determining what constitutes substantial alteration to granted claims. Under the old guideline, only when a post-grant amendment was to amend the granted claims by adding additional features which are in a strict and narrow genus-species relationship with at least one of the original granted claims would it be accepted. Starting January 1 2017, a post-grant claim amendment shall not be regarded as having introduced substantial alteration provided that the original object of the claimed invention remains achievable.

In view of the relaxation of the examination guideline, a patent owner's request to amend granted claims by including additional features may become allowable. To be more specific, adding a technical feature of an embodiment disclosed in the original specification into a granted claim, an amendment hardly permissible in the past is now possible so long as the same invention object can still be achieved. For instance, for a granted claim reciting the features of a pedal of a wheelchair, it is now acceptable to add the features relating to a swivel table disclosed in the specification as originally filed as a limitation to the said claim since the addition does not alter the object of the claimed invention.

A post-grant amendment shall be acceptable if it does not in any way alter or impair the original object of the claimed invention. In order that patent owners seeking post-grant amendments can make better preparations, it is worth observing how examiners will put into practice the new guideline during examination.

wu.jpg

Jun-yan Wu


Saint Island International Patent & Law Offices7th Floor, No. 248, Section 3Nanking East RoadTaipei 105-45, Taiwan, ROCTel: +886 2 2775 1823Fax: +886 2 2731 6377siiplo@mail.saint-island.com.twwww.saint-island.com.tw

more from across site and SHARED ros bottom lb

More from across our site

Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Gift this article